TradeStation

Get Cash Back and $0 Commissions
+ The Power of TradeStation

CLASS ACTION UPDATE for VERU, FXLV and SGLY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

ACCESSWIRE 25-Jan-2023 1:45 PM

NEW YORK, NY / ACCESSWIRE / January 25, 2023 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

Levi & Korsinsky, LLP, Wednesday, January 25, 2023, Press release picture

VERU Shareholders Click Here: https://www.zlk.com/pslra-1/veru-lawsuit-loss-submission-form?prid=35937&wire=1
FXLV Shareholders Click Here: https://www.zlk.com/pslra-1/f45-training-lawsuit-submission-form?prid=35937&wire=1
SGLY Shareholders Click Here: https://www.zlk.com/pslra-1/singularity-future-technology-lawsuit-submission-form?prid=35937&wire=1

* ADDITIONAL INFORMATION BELOW *

Veru Inc. (NASDAQ:VERU)

This lawsuit is on behalf of all investors who purchased or otherwise acquired Veru Inc. common stock between May 11, 2022 and November 9, 2022, inclusive.
Lead Plaintiff Deadline : February 6, 2023
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/veru-lawsuit-loss-submission-form?prid=35937&wire=1

According to the filed complaint, 1) the Company had withheld material adverse facts about the data from the sabizabulin Phase 3 trial and the Company's interactions with the United States Food and Drug Administration; 2) defendants misled Veru's shareholders to believe that the data from the sabizabulin Phase 3 trial was sufficient to support Emergency Use Authorization ("EUA") and even the submission of a New Drug Application without any further studies; and 3) the Company's filings concealed the true risks faced by Veru in gaining approval for its EUA request.

F45 Training Holdings Inc. (NYSE:FXLV)

This lawsuit is on behalf of all persons and entities that purchased or otherwise acquired the common stock of F45 pursuant and/or traceable to documents issued in connection with the Company's July 16, 2021 initial public offering.
Lead Plaintiff Deadline : February 6, 2023
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/f45-training-lawsuit-submission-form?prid=35937&wire=1

According to the filed complaint, 1) F45 Training could not maintain new franchise growth because it was offering more favorable payment terms to multi-unit franchisees; 2) F45 Training's lackluster pace of growth was also accompanied by a massive and unsustainable increase in F45 Training's accounts receivable and a similar, and equally unsustainable, decrease in its cash and cash equivalents; and 3) these practices were not sustainable at the time of the initial public offering, and when F45 Training could no longer sustain this defective business model, its growth rate and revenue plummeted.

Singularity Future Technology Ltd. (NASDAQ:SGLY)

SGLY Lawsuit on behalf of: investors who purchased February 12, 2021 - November 17, 2022
Lead Plaintiff Deadline : February 7, 2023
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/singularity-future-technology-lawsuit-submission-form?prid=35937&wire=1

According to the filed complaint, during the class period, Singularity Future Technology Ltd. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company had misrepresented the true educational background of its former CEO, Yang Jie; 2) Yang Jie had an outstanding arrest warrant in China, had committed forgery, and was the largest shareholder and VP of Finance for a Nasdaq-listed lending company, China Commercial Credit ("CCC"), which failed after reporting massive losses; (3) there existed material related party transactions with SOS Information Technology New York Inc. (where Jie's wife was Vice President) and Rich Trading, whose CEO was defendant Lei Nie, the husband of Singularity CFO Tuo Pan; (4) Singularity director John Levy had been a director at CCC from January 2013 through December 2016 as CCC failed amidst detailed allegations that Jie, when he was an executive and shareholder in CCC, misappropriated assets; (5) the Company lacked adequate internal controls, and as a result had a heightened risk of scrutiny and was ultimately subject to a United States Attorney's Office for the Southern District of New York and SEC investigation and action as well as a potential delisting by NASDAQ; and (6) as a result, the Company's statements during the class period about the historical financial and operational metrics and purported market opportunities did not accurately reflect the actual business, operations, and financial results and trajectory of the Company, and were materially false and misleading and lacked a factual basis.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Eduard Korsinsky, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP



View source version on accesswire.com:
https://www.accesswire.com/736749/CLASS-ACTION-UPDATE-for-VERU-FXLV-and-SGLY-Levi-Korsinsky-LLP-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders

Image for Press Release 1627150